Glaxo says Advair sales to top 4 bln pounds in 2008
LONDON, May 21 (Reuters) - GlaxoSmithKline Plc (GSK.L), the world's second-largest drugs company by turnover, said sales of its asthma drug Advair would top 4 billion pounds ($7.9 billion) this year.
"We are going to break 4 billion of sales this year with Advair," outgoing Chief Executive Jean-Pierre Garnier told shareholders at the company's annual meeting.
Advair is Glaxo's top selling drug, and had global sales of 3.5 billion pounds in 2007. ($1=.5088 Pound) (Reporting by Ben Hirschler, editing by Will Waterman)
© Thomson Reuters 2009 All rights reserved
Citadel enters the fray
Kenneth Griffin's powerful hedge fund has waded into the case of Goldman Sachs' purloined computer code, suing three of its former employees for setting up Teza Technologies. Full Article | Full Coverage
